COMMUNIQUÉS West-GlobeNewswire

ABLYNX ANNOUNCES WARRANT EXERCISE
30/04/2018
REGULATED INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
30/04/2018
REGULATED INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
30/04/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma Paris and Tarrytown, NY - April 30, 2018 - [...]
Sanofi : FDA accorde un examen prioritaire au cemiplimab dans le traitement potentiel du carcinome épidermoïde cutané au stade avancé
30/04/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) FDA accorde un examen prioritaire au cemiplimab dans le traitement potentiel du carcinome épidermoïde cutané au stade avancé Paris et Tarrytown (New [...]
Addex Reports 2017 Full Year Results and Provides Corporate Update
30/04/2018
Robust cash position of CHF45 million following capital raise in Q1 2018 Major global licensing agreement with Indivior in addiction Geneva, Switzerland, 30 April 2018 - Addex Therapeutics (SIX: ADXN), a leading company [...]
Innate Pharma to hold its AGM on May 29, 2018 and the release of its Reference document
30/04/2018
Innate pharma TO hold ITS annual general meeting of shareholders on May 29, 2018 and THE RELEASE OF ITS REFERENCE DOCUMENT (IN FRENCH) Marseille, France, April 30, 2018 Innate Pharma (the "Company" - Euronext Paris: [...]
Innate Pharma annonce la tenue de son AG annuelle le 29 mai 2018 et la mise à disposition de son DDR 2017
30/04/2018
INNATE PHARMA ANNONCE LA TENUE DE SON ASSEMBLEE GENERALE ANNUELLE LE 29 MAI 2018 A MARSEILLE ET LA MISE A DISPOSITION DE SON DOCUMENT DE REFERENCE 2017 Marseille, le 30 avril 2018 Innate Pharma (Euronext Paris : [...]
ABLYNX COMPLETES PATIENT RECRUITMENT IN THE PHASE IIb RESPIRE STUDY OF ITS INHALED ANTI-RSV NANOBODY ALX-0171
30/04/2018
REGULATED INFORMATION - INSIDE INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that it has successfully completed patient recruitment in the Phase IIb RESPIRE dose [...]
Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018
30/04/2018
Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018 - Received U.S. FDA clearance for Unyvero System and Unyvero LRT Cartridge; commercial U.S. roll-out initiated - Launched two novel CE-IVD [...]
LADAVRU® RECEIVES APPROVED FOR PUBLICATON NOTICE FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HOVERINK BIOTECHNOLOGIES ANNOUNCES.
30/04/2018
LOS ANGELES, CA, April 29, 2018 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today it has received its Notice of publication from the UNITED STATES PATENT AND TRADEMARK OFFICE for LADAVRU® Serial Number [...]
Flexion Therapeutics Announces Presentation of Positive FX201 Data at the Osteoarthritis Research Society International World Congress
29/04/2018
Results from preclinical osteoarthritis (OA) models demonstrate relief of pain, functional improvement and suggest disease-modifying efficacy following a single intra-articular injection BURLINGTON, Mass., April 29, [...]
HOVERINK BIOTECHNOLOGIES INITIATES PRIVATE PLACEMENT OF CONVERTIBLE NOTES
28/04/2018
LOS ANGELES, CA, April 27, 2018 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today it intends to offer, subject to market and other conditions, $2.5 million of Series A Convertible Notes, through a [...]
AC Immune Announces Results of Extraordinary Shareholders Meeting
27/04/2018
Lausanne, Switzerland, April 27, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced that the shareholders of the Company [...]
OPKO Health to Remain on the Tel Aviv Stock Exchange
27/04/2018
MIAMI, April 27, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) announced today it intends to remain on the Tel Aviv Stock Exchange (TASE) and withdraw its request to voluntarily delist its common stock from [...]
Melinta Therapeutics to Report First Quarter 2018 Financial Results on May 8, 2018
27/04/2018
NEW HAVEN, Conn., April 27, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
HTG Molecular Diagnostics to Announce First Quarter Financial Results and Host Conference Call on Thursday, May 10
27/04/2018
TUCSON, Ariz., April 27, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will [...]
Aurora Spine Corporation Announces 2017 Year End Results
27/04/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 27, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces [...]
MDxHealth releases 2017 Annual Report
27/04/2018
NEWS RELEASE REGULATED INFORMATION MDxHealth releases 2017 Annual Report and invitation to its Annual General Shareholders' Meeting IRVINE, CA, and HERSTAL, BELGIUM - 17:45 CEST, April 27, 2018 - MDxHealth SA (" [...]
MDxHealth publie le Rapport Annuel 2017
27/04/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS REGLEMENTÉES MDxHealth publie le Rapport Annuel 2017 et l'invitation à son Assemblée Générale d'Actionnaires IRVINE, CA, et HERSTAL, BELGIQUE - 17h45 CEST, vendredi 27 avril 2018 - [...]

Pages